Lemborexant for the Treatment of Residual Insomnia in Major Depressive Disorder (MDD)

Clinical trial NCT06843187 · TERMINATED

Trial details

NCT number: NCT06843187
Sponsor: Unity Health Toronto
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder(MDD)Insomnia Comorbid to Psychiatric Disorder

Start date: 2024-09-25
Primary completion: 2026-07-15
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.